Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Evexia Lifecare Ltd. shows significant underperformance compared to its peers in key metrics, particularly in growth and profitability, making it less attractive for investment. In contrast, Adani Enterprises Ltd. and Redington Ltd. are standout performers, showcasing strong financial health and growth potential, while Evexia stands out as financially weak and overvalued.
Strong revenue growth (1.53% YoY), high ROE (9.477%) and favorable PEG ratio (0.83) indicate a solid investment.
Robust EPS growth (20.5282), excellent ROE (17.1182), and low PEG (0.71) make it an attractive choice.